[{"Assets_0_Q2_USD":71320000.0,"EarningsPerShareBasic_1_Q2_USD":-0.52,"EarningsPerShareBasic_2_Q2_USD":-0.84,"EarningsPerShareDiluted_1_Q2_USD":-0.52,"EarningsPerShareDiluted_2_Q2_USD":-0.84,"NetIncomeLoss_1_Q2_USD":-11591000.0,"NetIncomeLoss_2_Q2_USD":-18689000.0,"StockholdersEquity_0_Q2_USD":-230308000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":22365663.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":22358092.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":22365663.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":22358092.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170814"}]